DE60116474D1 - Hcv ns2/3 fragmente und ihre verwendungen - Google Patents
Hcv ns2/3 fragmente und ihre verwendungenInfo
- Publication number
- DE60116474D1 DE60116474D1 DE60116474T DE60116474T DE60116474D1 DE 60116474 D1 DE60116474 D1 DE 60116474D1 DE 60116474 T DE60116474 T DE 60116474T DE 60116474 T DE60116474 T DE 60116474T DE 60116474 D1 DE60116474 D1 DE 60116474D1
- Authority
- DE
- Germany
- Prior art keywords
- hcv
- fragments
- renatured
- modulators
- assays
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
- C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Hydrogenated Pyridines (AREA)
- Detergent Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0006537.5A GB0006537D0 (en) | 2000-03-17 | 2000-03-17 | Assays and screening methods |
GB0006537 | 2000-03-17 | ||
PCT/IB2001/000527 WO2001068818A2 (en) | 2000-03-17 | 2001-03-14 | Hcv ns2/3 fragments and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60116474D1 true DE60116474D1 (de) | 2006-03-30 |
DE60116474T2 DE60116474T2 (de) | 2006-09-07 |
Family
ID=9887885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60116474T Expired - Fee Related DE60116474T2 (de) | 2000-03-17 | 2001-03-14 | Hcv ns2/3 fragmente und ihre verwendungen |
Country Status (10)
Country | Link |
---|---|
US (1) | US7078215B2 (de) |
EP (1) | EP1278867B1 (de) |
JP (1) | JP2003526361A (de) |
AT (1) | ATE315093T1 (de) |
AU (1) | AU4269401A (de) |
CA (1) | CA2403405A1 (de) |
DE (1) | DE60116474T2 (de) |
ES (1) | ES2254380T3 (de) |
GB (1) | GB0006537D0 (de) |
WO (1) | WO2001068818A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0302558A3 (en) * | 2000-12-15 | 2012-03-28 | Boehringer Ingelheim Ca Ltd | Purified active hcv ns2/3 protease |
DE60304435T2 (de) * | 2004-01-19 | 2006-08-24 | Ares Trading S.A. | Verfahren zur Reinigung von in Bakterien exprimierten Proteinen |
US20090233266A1 (en) * | 2005-03-10 | 2009-09-17 | The Rockefeller University | Structure of the hepatitis c virus ns2 protein |
EP1945797B1 (de) * | 2005-10-28 | 2012-05-30 | Boehringer Ingelheim International GmbH | Hepatitis-c-virus-ns2/3-aktivitätstest |
EP2388312A1 (de) | 2010-05-17 | 2011-11-23 | Curetis AG | Universell anwendbarer Lysepuffer und Verarbeitungsverfahren zur Lyse von Körperproben |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888762A (en) | 1990-06-05 | 1999-03-30 | Centre National De La Recherche Scientifique (Cnrs) | Neurotropic growth factors comprising a homeobox peptide |
IT1277914B1 (it) * | 1995-08-22 | 1997-11-12 | Angeletti P Ist Richerche Bio | Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e |
US6242187B1 (en) * | 1996-01-29 | 2001-06-05 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US5837464A (en) * | 1996-01-29 | 1998-11-17 | Virologic, Inc. | Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
US6280940B1 (en) * | 1998-08-05 | 2001-08-28 | Agouron Pharmaceuticals, Inc. | Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
WO2001016379A1 (en) * | 1999-08-30 | 2001-03-08 | Merck & Co., Inc. | Hepatitis c virus replication inhibitors |
HUP0302558A3 (en) * | 2000-12-15 | 2012-03-28 | Boehringer Ingelheim Ca Ltd | Purified active hcv ns2/3 protease |
-
2000
- 2000-03-17 GB GBGB0006537.5A patent/GB0006537D0/en not_active Ceased
-
2001
- 2001-03-14 EP EP01915613A patent/EP1278867B1/de not_active Expired - Lifetime
- 2001-03-14 JP JP2001567302A patent/JP2003526361A/ja not_active Withdrawn
- 2001-03-14 CA CA002403405A patent/CA2403405A1/en not_active Abandoned
- 2001-03-14 ES ES01915613T patent/ES2254380T3/es not_active Expired - Lifetime
- 2001-03-14 WO PCT/IB2001/000527 patent/WO2001068818A2/en active IP Right Grant
- 2001-03-14 AU AU42694/01A patent/AU4269401A/en not_active Abandoned
- 2001-03-14 DE DE60116474T patent/DE60116474T2/de not_active Expired - Fee Related
- 2001-03-14 US US10/221,943 patent/US7078215B2/en not_active Expired - Fee Related
- 2001-03-14 AT AT01915613T patent/ATE315093T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE315093T1 (de) | 2006-02-15 |
WO2001068818A3 (en) | 2002-03-21 |
GB0006537D0 (en) | 2000-05-10 |
CA2403405A1 (en) | 2001-09-20 |
JP2003526361A (ja) | 2003-09-09 |
EP1278867A2 (de) | 2003-01-29 |
DE60116474T2 (de) | 2006-09-07 |
US7078215B2 (en) | 2006-07-18 |
WO2001068818A2 (en) | 2001-09-20 |
AU4269401A (en) | 2001-09-24 |
EP1278867B1 (de) | 2006-01-04 |
ES2254380T3 (es) | 2006-06-16 |
US20040054134A1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE212037T1 (de) | Inhibitoren von serinproteasen, insbesondere von ns3-protease des hepatitis-c-virus | |
DK1268847T3 (da) | Ubiquitin-ligaseassay | |
ATE421973T1 (de) | Inzektizide proteinen von bacillus thuringiensis | |
DE60111534D1 (de) | Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren | |
ATE294867T1 (de) | Mutierte alpha-amylase aus bacillus licheniformis,die eine modifizierung von resten a210, h405 und/oder t412 enthält | |
DE60326259D1 (de) | Neue fructosylpeptidoxidase und deren nutzung | |
IT1272179B (it) | Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv. | |
ATE500323T1 (de) | Subtilisin-variante | |
DE69842027D1 (de) | Mutanten der alpha-amylase | |
ATE259512T1 (de) | Tragbares telefon und einschaltverfahren | |
NO20053595L (no) | Escitalopramdibromid samt fremgangsmate ved fremstilling derav. | |
NO20015785L (no) | I dets vesentlige oljefrie cyklosporinblandinger | |
DE60219068D1 (de) | Substituierte 2-amino-zykloalkankarboxamide und ihre verwendung als zysteinprotease-inhibitoren | |
ATE426603T1 (de) | Acyl- und sulfonylderivative 6,9- disubstitutierter 2-(trans-1,4-diaminocyclohexyl)-purine und ihre verwendung als antiproliferative mittel | |
ID30417A (id) | Popok sekali pakai dan proses pembuatannya | |
DE60009888D1 (de) | Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen | |
ATE267867T1 (de) | Chimäre serinproteasen | |
NO20031860L (no) | Kahalalid F | |
ITRM950573A0 (it) | Procedimento per produrre - in forma pura ed in quantita' elevate- polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e metodologia per riprodurre e saggiare efficacemente in vitro l'attivi-ta' proteolitica dei suddetti polipeptidi | |
DE60116474D1 (de) | Hcv ns2/3 fragmente und ihre verwendungen | |
WO2006024020A3 (en) | Hcv non-structural protein mutants and uses thereof | |
ATE253059T1 (de) | Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2- one und ihre verwendung als lipase-hemmer | |
BR0213278B1 (pt) | composição vedante e seu uso. | |
DE60201337D1 (de) | Kontinuierliche umesterung von alkoxysilanen | |
ATE326520T1 (de) | Teilchen für flüssige zubereitungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |